The Red Section | Published:

An Evidence-Based Treatment Algorithm for IBS Based on a Bacterial/SIBO Hypothesis: Part 2

The American Journal of Gastroenterology volume 105, pages 12271230 (2010) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    . Evaluating a bacterial hypothesis in IBS using a modification of Koch's postulates: Part 1. Am J Gastroenterology 2010;105:718–721.

  2. 2.

    , , et al. Altered counts of small bowel bacteria in patients with irritable bowel syndrome. Gut 2007;56:802–808.

  3. 3.

    , , . Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000;95:3503–3506.

  4. 4.

    , , . Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003;98:412–419.

  5. 5.

    , . Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol 2005;100:1566–1570.

  6. 6.

    , , et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005;21:1391–1395.

  7. 7.

    , , . Evaluating the role of small intestinal bacterial overgrowth (SIBO) in diarrhea predominant irritable bowel syndrome (IBS-D) patients utilizing the glucose breath test (gbt). Gastroenterology 2005;128:A460.

  8. 8.

    , , et al Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 2005;22:1157–1160.

  9. 9.

    , . Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin. Minerva Gastroenterol Dietol 2006;52:89–95.

  10. 10.

    , , et al. Bowel patterns among subjects not seeking health care. Gastroenterology 1982;83:529–534.

  11. 11.

    , . Functional bowel disorders in apparently healthy people. Gastroenterology 1980;79:283–288.

  12. 12.

    , , et al. Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS. Dig Dis Sci 2008;53:169–74.

  13. 13.

    , , et al. Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2000;14:551–556.

  14. 14.

    , , et al. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome. Ann Intern Med 2006;145:557–563.

  15. 15.

    , , et al. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol 2006;101:326–333.

  16. 16.

    , , et al. Rifaximin for the treatment of diarrhea-associated irritable bowel syndrome: short term treatment leading to long term sustained response. Gastroenterology 2008;134:A545.

  17. 17.

    , , et al. Rifaximin treatment for 2 weeks provides acute and sustained relief over 12 weeks of IBS symptoms in non-constipated irritable bowel syndrome: results from 2 North American phase 3 trials (Target 1 and Target 2). Gastroenterology 2010;138:S64–S65.

  18. 18.

    , , et al. Functional bowel disorders. Gastroenterology 2006;130:1480–1491.

  19. 19.

    , , et al. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol 2007;102:837–841.

  20. 20.

    , , et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments ileal contractile activity. Am J Physiol Gastrointest Liver Physiol 2006;290:G1089–G1095.

  21. 21.

    , , et al. Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study. Dig Dis Sci 2006;51:1297–1301.

  22. 22.

    , , et al. A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test. J Clin Gastroenterol 2009; e-pub ahead of print 3 December 2009.

  23. 23.

    , , et al. Evaluating breath methane as a diagnostic test for constipation-predominant IBS. Dig Dis Sci 2010;55:398–403.

  24. 24.

    , . Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS. Dig Dis Sci 2009; e-pub ahead of print 16 October 2009.

  25. 25.

    , , et al. Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth. Dig Dis Sci 2002;47:2639–2643.

  26. 26.

    , , et al. Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth. Gastroenterol Hepatol 2009;5:435–442.

Download references

Author information

Affiliations

  1. GI Motility Program, Cedars–Sinai Medical Center, Los Angeles, California, USA.

    • Mark Pimentel

Authors

  1. Search for Mark Pimentel in:

Competing interests

Guarantor of the article: Mark Pimentel, MD, FRCP(C).

Financial support: None.

Potential competing interests: None.

Corresponding author

Correspondence to Mark Pimentel.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/ajg.2010.125

Further reading

  • Evidence-based clinical practice guidelines for irritable bowel syndrome

    • Shin Fukudo
    • , Hiroshi Kaneko
    • , Hirotada Akiho
    • , Masahiko Inamori
    • , Yuka Endo
    • , Toshikatsu Okumura
    • , Motoyori Kanazawa
    • , Takeshi Kamiya
    • , Ken Sato
    • , Toshimi Chiba
    • , Kenji Furuta
    • , Shigeru Yamato
    • , Tetsuo Arakawa
    • , Yoshihide Fujiyama
    • , Takeshi Azuma
    • , Kazuma Fujimoto
    • , Tetsuya Mine
    • , Soichiro Miura
    • , Yoshikazu Kinoshita
    • , Kentaro Sugano
    •  & Tooru Shimosegawa

    Journal of Gastroenterology (2015)